Tsumura & Co.
Tsumura & Co. scores highest on Price (82) and lowest on Nitro (48). Its PosiPenta is 61.45 out of 100, better than most similar companies.
On the Penta Grid this week, Tsumura & Co. is Grid #3 of 26 in the Healthcare sector in Japan, and Grid #50 of 447 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Tsumura & Co. | 61.45 | 82 | 69 | 48 | 48 | 60 |
| Create SD Holdings Co., Ltd. | 72.22 | 67 | 85 | 62 | 75 | 73 |
| Kaken Pharmaceutical Co., Ltd. | 51.02 | 37 | 53 | 50 | 56 | 59 |
| Sumitomo Pharma Co., Ltd. | 47.41 | 62 | 32 | 22 | 76 | 44 |
| Zeria Pharmaceutical Co., Ltd. | 56.59 | 86 | 62 | 37 | 40 | 57 |
| Tsuruha Holdings Inc. | 55.54 | 59 | 72 | 35 | 48 | 64 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 9.16 |
| P/B ratio | 0.87 |
EEarnings
| Trailing EPS | ₹246.66 |
| Forward EPS | ₹252.83 |
NNitro
| Price | 2260.43 |
| 52-week high | 2665.42 |
| 52-week low | 2118.78 |
| Fall from 52-week high | 15.2% |
TTorque
| Return on equity (ROE) | 9.32% |
| Debt-to-equity | 0.39 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹16,850 Cr |
| Insider holding | 5.54% |
| Dividend yield | 4.18% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tsumura & Co.'s PosiPenta score?
Tsumura & Co.'s PosiPenta is 61.45 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Tsumura & Co. stand on the Penta Grid?
On the Penta Grid this week, Tsumura & Co. is Grid #3 of 26 in the Healthcare sector in Japan, and Grid #50 of 447 in Japan.
Which PosiPenta pillar is strongest for Tsumura & Co.?
Price (valuation), with a score of 82 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Tsumura & Co.?
Nitro (momentum), with a score of 48 out of 100: around the middle of similar companies.
PositoAI is for research and education only and is not investment advice.